Last week it was announced that the National Institute for Health & Clinical Excellence (NICE) was to lose its powers to approve medicines for use in the UK NHS. While some see this as a retrograde step, its main consequence is that from 2014 the UK will adopt a Value Based Pricing (VBP) approach to [...]